Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gross

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
Annals of Internal Medicine|March 7, 2012
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panelMelanie A Thompson, Michael J Mugavero, K Rivet Amico, et al.
AIDS (London, England)|April 8, 2021
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settingsTanakorn Apornpong, Beatriz Grinsztejn, Michael Hughes, et al.
The Lancet. HIV|October 2, 2015
Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysisEdward J Mills, Richard Lester, Kristian Thorlund, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Non-invasive Temporal Interference Stimulation of the Hippocampus Suppresses Epileptic Biomarkers in Patients with Epilepsy: Biophysical Differences between Kilohertz and Amplitude Modulated StimulationFlorian Missey, Emma Acerbo, Adam Dickey, et al.
Epilepsy & Behavior : E&B|September 15, 2018
Ripple oscillations in the left temporal neocortex are associated with impaired verbal episodic memory encodingZachary J Waldman, Liliana Camarillo-Rodriguez, Inna Chervenova, et al.
The Lancet. HIV|August 3, 2019
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn, Michael D Hughes, Justin Ritz, et al.
Journal of the International AIDS Society|August 30, 2022
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon, Michael D Hughes, Robert Salata, et al.
Epilepsia|March 25, 2010
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsyRobert Fisher, Vicenta Salanova, Thomas Witt, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV InfectionLeila B Giron, Qin Liu, Opeyemi S Adeniji, et al.
Nature Communications|April 10, 2024
Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infectionLeila B Giron, Qin Liu, Opeyemi S Adeniji, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
Annals of Internal Medicine|March 7, 2012
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panelMelanie A Thompson, Michael J Mugavero, K Rivet Amico, et al.
AIDS (London, England)|April 8, 2021
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settingsTanakorn Apornpong, Beatriz Grinsztejn, Michael Hughes, et al.
The Lancet. HIV|October 2, 2015
Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysisEdward J Mills, Richard Lester, Kristian Thorlund, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2024
Non-invasive Temporal Interference Stimulation of the Hippocampus Suppresses Epileptic Biomarkers in Patients with Epilepsy: Biophysical Differences between Kilohertz and Amplitude Modulated StimulationFlorian Missey, Emma Acerbo, Adam Dickey, et al.
Epilepsy & Behavior : E&B|September 15, 2018
Ripple oscillations in the left temporal neocortex are associated with impaired verbal episodic memory encodingZachary J Waldman, Liliana Camarillo-Rodriguez, Inna Chervenova, et al.
The Lancet. HIV|August 3, 2019
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn, Michael D Hughes, Justin Ritz, et al.
Journal of the International AIDS Society|August 30, 2022
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon, Michael D Hughes, Robert Salata, et al.
Epilepsia|March 25, 2010
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsyRobert Fisher, Vicenta Salanova, Thomas Witt, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV InfectionLeila B Giron, Qin Liu, Opeyemi S Adeniji, et al.
Nature Communications|April 10, 2024
Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infectionLeila B Giron, Qin Liu, Opeyemi S Adeniji, et al.
Pageof 25